3 Rules for the Trump Pandemic One: Don’t trust the

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
151
3 Rules for the Trump Pandemic

One: Don’t trust the president.


By Paul Krugman

Opinion Columnist
March 19, 2020

https://www.nytimes.com/2020/03/19/opinion/tr...4620200320

So Donald Trump is now calling Covid-19 the “Chinese virus.” Of course he is: Racism and blaming other people for his own failures are the defining features of his presidency. But if we’re going to give it a nickname, much better to refer to it as the “Trump pandemic.”

True, the virus didn’t originate here. But the U.S. response to the threat has been catastrophically slow and inadequate, and the buck stops with Trump, who minimized the threat and discouraged action until just a few days ago.

Compare, for example, America’s handling of the coronavirus with that of South Korea. Both countries reported their first case on Jan. 20. But Korea moved quickly to implement widespread testing; it has used the data from that testing to guide social distancing and other containment measures; and the disease appears to be on the wane there.

In the U.S., by contrast, testing has barely begun — we’ve tested only 60,000 people compared with South Korea’s 290,000, even though we have six times its population, and the number of cases here appears to be skyrocketing.


The details of our failure are complex, but they all flow ultimately from Trump’s minimization of the threat: He was asserting that Covid-19 was no worse than the flu just last week (although true to form, he’s now claiming to have known all along that a pandemic was coming).

Why did Trump and his team deny and delay? All the evidence suggests that he didn’t want to do or say anything that might drive down stock prices, which he seems to regard as the key measure of his success. That’s presumably why as late as Feb. 25 Larry Kudlow, the administration’s chief economist, declared that the U.S. had “contained” the coronavirus, and that the economy was “holding up nicely.”

Well, that was a bad bet. Since then, the stock market has more or less given up all its gains under the Trump presidency. More important, the economy is clearly in free-fall. So what should we do now?


I’ll leave health policy to the experts. On economic policy, I’d suggest three principles. First, focus on hardship, not G.D.P. Second, stop worrying about incentives to work. Third, don’t trust Trump.

On the first point: Many of the job losses we’ll experience over the next few months will be not just unavoidable but actually desirable. We want workers who are or might be sick to stay home, to “flatten the curve” of the virus’s spread.

We want to partly or wholly close large business establishments, like auto plants, that could act as human petri dishes. We want to close restaurants, bars and nonessential retail establishments.

Now, there will surely be additional, unnecessary job losses caused by a plunge in consumer and business spending, which is why we should be engaged in substantial overall stimulus. But policy can’t and shouldn’t prevent widespread temporary job loss.

What policy can do is reduce the hardship facing those who are temporarily out of work. That means that we need to spend much more on programs like paid sick leave, unemployment benefits, food stamps and Medicaid that aid Americans in distress, who need far more help than they’ll get from an across-the-board cash drop. This spending would also provide stimulus, but that’s a secondary concern.

Which brings me to my second point. The usual suspects are already objecting that helping Americans in need reduces their incentive to work. That’s a lousy argument even in good times, but it’s absurd in the face of a pandemic.

And state governments that have been trying, with encouragement from the Trump administration, to reduce public assistance by imposing work requirements should suspend all such requirements, immediately.

Finally, about Trump: Over the past few days state TV, I mean Fox News, and right-wing pundits have abruptly pivoted from dismissing Covid-19 as a liberal hoax to demanding an end to all criticism of the president in a time of national emergency. This should come as no surprise.

But this is where the history of the Trump pandemic — all those wasted weeks when we did nothing because Donald Trump didn’t want to hear anything that might hurt him politically — becomes relevant. It shows that even when American lives are at risk, this administration’s policy is all about Trump, about what he thinks will make him look good, never mind the national interest.

What this means is that as Congress allocates money to reduce the economic pain from Covid-19, it shouldn’t give Trump any discretion over how the money is spent. For example, while it may be necessary to provide funds for some business bailouts, Congress must specify the rules for who gets those funds and under what conditions. Otherwise you know what will happen: Trump will abuse any discretion to reward his friends and punish his enemies. That’s just who he is.

Dealing with the coronavirus would be hard in the best of circumstances. It will be especially hard when we know that we can’t trust either the judgment or the motives of the man who should be leading the response. But you go into a pandemic with the president you have, not the president you wish you had.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Plata Hits $1 Billion ARR in Record Digital Bank Growth

Updated Category News Views 14

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Continue Reading
Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 8

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
eGlint's Rapid Tech Revolutionizes Proteomics with Win

Updated Category News Views 5

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Continue Reading
Steel Dynamics' Q3 2026: Record Shipments Boost Profits

Updated Category News Views 5

Steel Dynamics Shatters Records in Q3 2026 If there was any doubt about Steel Dynamics' ability to ride the waves in the steel and aluminum market, the third quarter of 2026 put that to rest. With a record-breaking 3.8 million tons of steel shipped and net sales reaching a steep $6.5 billion, this isn't just business as usual—it's smashing their own ceiling. Operating...

Continue Reading
Zika Virus: A Surprising Ally in Brain Cancer Fight

Updated Category News Views 8

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

Continue Reading
DOCS Faces Investor Legal Battle for Alleged Misconduct

Updated Category News Views 8

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Continue Reading
Chemours Faces Investor Fraud Suit: Action Needed Now

Updated Category News Views 10

A Messy Situation Unfolds for Chemours Company You know, stumbling upon a battle scene like this isn't something I enjoy, but here we have Chemours Company (NYSE: CC) embroiled in a securities fraud lawsuit. It's like catching wind of a brawl outside your favorite tavern—can't ignore it, can you? The Lawsuit's Crux and Key Dates to Watch Here's the rundown. The fight...

Continue Reading
Firmable's Tech Intelligence: New Edge in B2B Sales

Updated Category News Views 14

New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 10

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
QFIN Faces Class Action: Investors' Role Explored

Updated Category News Views 8

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Continue Reading

Top 5 Most Recently Viewed Articles

Gold Mining Boom: A New Era of Growth and Innovation

Updated Category News Views 190

Introduction to Gold Mining Growth In recent years, the demand for gold has surged significantly, which in turn has fueled substantial growth in gold mining operations across North America. With various industries utilizing gold for its unique properties, these developments signal a new chapter for the gold mining sector. Market Growth Projections According to recent...

Continue Reading
Federal Spending Surges amidst Efficiency Initiatives

Updated Category News Views 209

Record Federal Spending Amid Efforts for Efficiency The U.S. federal spending reached a staggering $603.4 billion last month, even as initiatives aimed at streamlining operations are underway, led by influential figures in the business sector. The Current Spending Snapshot Recent statistics highlight a dramatic spike in spending, which has surged by $36 billion compared...

Continue Reading
Insulet's Initiatives for Diabetes Awareness Month and Beyond

Updated Category News Views 90

Insulet Corporation's Commitment to Diabetes Awareness Insulet Corporation (NASDAQ: PODD), recognized as a leader in tubeless insulin pump technology, is gearing up for an impactful November as it observes National Diabetes Awareness Month and World Diabetes Day. The company has exciting plans to engage communities and individuals in understanding diabetes and its...

Continue Reading
Exploring the Future of Aircraft Tire Markets Through 2035

Updated Category News Views 143

Growth Prospects of the Aircraft Tire Market The aircraft tire market is projected for significant growth from 2025 to 2035, anticipated to expand from USD 2,030.1 million to USD 3,704.8 million. This translates to a compound annual growth rate (CAGR) of 6.2%. The driving forces behind this increase include the ongoing expansion of commercial aviation, rising global air...

Continue Reading
DuPont and Habitat for Humanity: A Lasting Partnership

Updated Category News Views 142

DuPont Renews Global Partnership with Habitat for Humanity DuPont and Habitat for Humanity International are excited to announce the continuation of their impactful collaboration. With this renewed annual partnership, DuPont will be donating products, as well as providing essential cash contributions to support Habitat for Humanity's valuable projects worldwide....

Continue Reading